Mutation scanning the GJB1 gene with high-resolution melting analysis:: Implications for mutation scanning of genes for Charcot-Marie-Tooth disease

被引:47
作者
Kennerson, L. [1 ]
Warburton, Trent
Nelis, Eva
Brewer, Megan
Polly, Patsie
De Jonghe, Peter
Timmerman, Vincent
Nicholson, Garth A.
机构
[1] ANZAC Res Inst, Northcott Neurosci Lab, Concord, NSW 2139, Australia
[2] Concord Hosp, Mol Med Lab, Concord, NSW, Australia
[3] Univ Antwerp VIB, Neurogenet Grp, Dept Mol Genet, B-2610 Antwerp, Belgium
[4] Univ Antwerp VIB, Peripheral Neuropathol Grp, Dept Mol Genet, B-2610 Antwerp, Belgium
[5] Univ New S Wales, Dept Pathol, Sch Med Sci, Kensington, NSW 2033, Australia
关键词
D O I
10.1373/clinchem.2006.080010
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: X-linked Charcot-Marie-Tooth type 1 disease has been associated with 280 mutations in the GJB1 [gap junction protein, beta 1, 32kDa (connexin 32, Charcot-Marie-Tooth neuropathy, X-linked)] gene. High-resolution melting analysis with an automated instrument can be used to scan DNA for alterations, but its use in X-linked disorders has not been described. Methods: A 96-well LightScanner for high resolution melting analysis was used to scan amplicons of the GJB1 gene. All mutations reported in this study had been confirmed previously by sequence analysis. DNA samples were amplified with the double-stranded DNA-binding dye LC Green Plus. Melting curves were analyzed as fluorescence difference plots. The shift and curve shapes of melting profiles were used to distinguish controls from patient samples. Results: The method detected each of the 23 mutations used in this study. Eighteen known mutations provided validation of the high-resolution melting method and a further 5 mutations were identified in a blind study. Altered fluorescence difference curves for all the mutations were easily distinguished from the wild-type melting profile. Conclusion: High-resolution melting analysis is a simple, sensitive, and cost-efficient alternative method to scan for gene mutations in the GJB1 gene. The technology has the potential to reduce sequencing burden and would be suitable for mutation screening of exons of large multiexon genes that have been discovered to be associated with Charcot Marie Tooth neuropathy. (c) 2007 American Association for Clinical Chemistry
引用
收藏
页码:349 / 352
页数:4
相关论文
共 9 条
[1]   CONNEXIN MUTATIONS IN X-LINKED CHARCOT-MARIE-TOOTH DISEASE [J].
BERGOFFEN, J ;
SCHERER, SS ;
WANG, S ;
SCOTT, MO ;
BONE, LJ ;
PAUL, DL ;
CHEN, K ;
LENSCH, MW ;
CHANCE, PF ;
FISCHBECK, KH .
SCIENCE, 1993, 262 (5142) :2039-2042
[2]   Amplicon melting analysis with labeled primers: A closed-tube method for differentiating homozygotes and heterozygotes [J].
Gundry, CN ;
Vandersteen, JG ;
Reed, GH ;
Pryor, RJ ;
Chen, J ;
Wittwer, CT .
CLINICAL CHEMISTRY, 2003, 49 (03) :396-406
[3]   Amplicon DNA melting analysis for mutation scanning and genotyping: Cross-platform comparison of instruments and dyes [J].
Herrmann, MG ;
Durtschi, JD ;
Bromley, LK ;
Wittwer, CT ;
Voelkerding, KV .
CLINICAL CHEMISTRY, 2006, 52 (03) :494-503
[4]   Mutations of the noncoding region of the connexin32 gene in X-linked dominant Charcot-Marie-Tooth neuropathy [J].
Ionasescu, VV ;
Searby, C ;
Ionasescu, R ;
Neuhaus, IM ;
Werner, R .
NEUROLOGY, 1996, 47 (02) :541-544
[5]   Quantitative heteroduplex analysis for single nucleotide polymorphism genotyping [J].
Palais, RA ;
Liew, MA ;
Wittwer, CT .
ANALYTICAL BIOCHEMISTRY, 2005, 346 (01) :167-175
[6]  
SKRE H, 1974, CLIN GENET, V6, P98
[7]   High-resolution melting analysis for detection of internal tandem duplications [J].
Vaughn, CP ;
Elenitoba-Johnson, KSJ .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2004, 6 (03) :211-216
[8]   High-resolution genotyping by amplicon melting analysis using LCGreen [J].
Wittwer, CT ;
Reed, GH ;
Gundry, CN ;
Vandersteen, JG ;
Pryor, RJ .
CLINICAL CHEMISTRY, 2003, 49 (06) :853-860
[9]   High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution [J].
Zhou, LM ;
Wang, L ;
Palais, R ;
Pryor, R ;
Wittwer, CT .
CLINICAL CHEMISTRY, 2005, 51 (10) :1770-1777